MindWalk Holdings Corp. SEC filings HYFT
MindWalk Holdings Corp. has 287 filings in SEC EDGAR's recent list, going back to Aug 31, 2017. Its latest annual report, Form 20-F, was filed on Jul 23, 2026 for the period ended Apr 30, 2026. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 23, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 24, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Feb 27, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 10, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 10, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jul 7, 2023 | — |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HYFT (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Victoria
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1715925
- Former names
- ImmunoPrecise Antibodies Ltd. (until Sep 3, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.